Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 69.00
-1.00 (-1.43%)
Aug 6, 2026, 12:39 PM JST
Chiome Bioscience Market Cap
Chiome Bioscience has a market cap or net worth of 5.52 billion as of August 5, 2026. Its market cap has decreased by -42.58% in one year.
Market Cap
5.52B
Enterprise Value
4.47B
Revenue
601.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
69.00
ChartMarket Cap Chart
Since December 20, 2011, Chiome Bioscience's market cap has increased from 470.00M to 5.52B, an increase of 1,075.37%. That is a compound annual growth rate of 18.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 5.52B | -24.12% |
| Dec 30, 2025 | 7.28B | -58.55% |
| Dec 30, 2024 | 17.56B | 149.35% |
| Dec 29, 2023 | 7.04B | -18.27% |
| Dec 30, 2022 | 8.62B | 9.67% |
| Dec 30, 2021 | 7.86B | 6.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.04B |
| Carna Biosciences | 6.32B |
| CellSource | 6.11B |
| Chordia Therapeutics | 6.10B |
| Noile-Immune Biotech | 5.99B |
| PRISM BioLab Co.,LTD | 5.77B |
| Soiken Holdings | 5.57B |
| Cyfuse Biomedical K.K. | 5.20B |